Amgen (AMGN)
(Delayed Data from NSDQ)
$319.66 USD
+2.18 (0.69%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $319.25 -0.41 (-0.13%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for Amgen Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 6,717.00 | 6,552.00 | 5,893.00 | 7,264.00 | 7,842.00 |
Depreciation/Amortization & Depletion | 4,071.00 | 3,417.00 | 3,398.00 | 3,601.00 | 2,206.00 |
Net Change from Assets/Liabilities | -484.00 | -733.00 | -1,194.00 | -216.00 | -731.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -1,833.00 | 485.00 | 1,164.00 | -152.00 | -167.00 |
Net Cash From Operating Activities | 8,471.00 | 9,721.00 | 9,261.00 | 10,497.00 | 9,150.00 |
Property & Equipment | -1,112.00 | -936.00 | -880.00 | -608.00 | -618.00 |
Acquisition/ Disposition of Subsidiaries | -26,989.00 | -3,709.00 | -2,529.00 | 0.00 | -13,617.00 |
Investments | 1,672.00 | -1,387.00 | 4,177.00 | -4,718.00 | 19,996.00 |
Other Investing Activities | 225.00 | -12.00 | -35.00 | -75.00 | -52.00 |
Net Cash from Investing Activities | -26,204.00 | -6,044.00 | 733.00 | -5,401.00 | 5,709.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | -6,360.00 | -4,975.00 | -3,486.00 | -7,702.00 |
Issuance (Repayment) of Debt | 26,323.00 | 6,919.00 | 795.00 | 2,464.00 | -4,514.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -4,556.00 | -4,196.00 | -4,013.00 | -3,755.00 | -3,509.00 |
Other Financing Activities | -719.00 | -400.00 | -78.00 | -90.00 | -42.00 |
Net Cash from Financing Activities | 21,048.00 | -4,037.00 | -8,271.00 | -4,867.00 | -15,767.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 3,315.00 | -360.00 | 1,723.00 | 229.00 | -908.00 |
Cash at Beginning of Period | 7,629.00 | 7,989.00 | 6,266.00 | 6,037.00 | 6,945.00 |
Cash at End of Period | 10,944.00 | 7,629.00 | 7,989.00 | 6,266.00 | 6,037.00 |
Diluted Net EPS | 12.49 | 12.11 | 10.28 | 12.31 | 12.88 |
Fiscal Year End for Amgen Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 633.00 | -113.00 | 6,717.00 | 5,950.00 | 4,220.00 |
Depreciation/Amortization & Depletion | 2,799.00 | 1,399.00 | 4,071.00 | 2,691.00 | 1,796.00 |
Net Change from Assets/Liabilities | -570.00 | -692.00 | -484.00 | 414.00 | 361.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 286.00 | 95.00 | -1,833.00 | -1,122.00 | -1,204.00 |
Net Cash From Operating Activities | 3,148.00 | 689.00 | 8,471.00 | 7,933.00 | 5,173.00 |
Property & Equipment | -468.00 | -230.00 | -1,112.00 | -863.00 | -615.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -26,989.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 1,672.00 | 1,674.00 | 1,675.00 |
Other Investing Activities | 34.00 | 13.00 | 225.00 | 74.00 | 87.00 |
Net Cash from Investing Activities | -434.00 | -217.00 | -26,204.00 | 885.00 | 1,147.00 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -1,400.00 | 0.00 | 26,323.00 | 22,327.00 | 23,076.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -2,417.00 | -1,208.00 | -4,556.00 | -3,416.00 | -2,276.00 |
Other Financing Activities | -540.00 | -500.00 | -719.00 | -617.00 | -501.00 |
Net Cash from Financing Activities | -4,357.00 | -1,708.00 | 21,048.00 | 18,294.00 | 20,299.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1,643.00 | -1,236.00 | 3,315.00 | 27,112.00 | 26,619.00 |
Cash at Beginning of Period | 10,944.00 | 10,944.00 | 7,629.00 | 7,629.00 | 7,629.00 |
Cash at End of Period | 9,301.00 | 9,708.00 | 10,944.00 | 34,741.00 | 34,248.00 |
Diluted Net EPS | 1.38 | -0.21 | 1.42 | 3.22 | 2.57 |